Spravato vs. Antidepressants: Which One Is Right For You?

Vinay Saranga • May 28, 2024

This is a subtitle for your new post

A woman is holding a floral shirt in front of a mirror.

Depression is a serious and often debilitating condition that affects millions of people worldwide. It can disrupt daily life, relationships, and overall well-being. Traditional antidepressants have been a cornerstone of depression treatment for many years, but they don't work for everyone. Recently, a new treatment called Spravato (esketamine) has emerged, offering hope to those who haven't found relief with traditional medications.

 

Let’s explore the differences between Spravato and traditional antidepressants, and how they can impact the lives of those suffering from depression.

 

Traditional Antidepressants: A Brief Overview

 

Traditional antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), work by increasing the levels of certain neurotransmitters in the brain. These chemicals, like serotonin and norepinephrine, play a key role in mood regulation. Common SSRIs include Prozac (fluoxetine), Zoloft (sertraline), and Lexapro (escitalopram). SNRIs include medications like Effexor (venlafaxine) and Cymbalta (duloxetine).

 

How Antidepressants Work

 

Antidepressants are typically taken daily in pill form. They gradually build up in the body and begin to affect brain chemistry, which can take several weeks. This delayed onset can be challenging for patients who need quick relief from their symptoms.

 

Limitations of Antidepressants

 

While many people find relief with antidepressants, they don't work for everyone. Some patients may not experience any improvement, or they might encounter significant side effects such as weight gain, sexual dysfunction, and fatigue. For those who do not respond to these medications, the search for an effective treatment can be frustrating and disheartening.

 

Enter Spravato: A New Hope


Spravato is a newer treatment that offers an alternative for those with treatment-resistant depression (TRD). Approved by the FDA in 2019, Spravato contains esketamine, a form of ketamine. Ketamine has been used as an anesthetic for decades and has gained attention for its rapid antidepressant effects.

 

How Spravato Works

 

Unlike traditional antidepressants, which target serotonin and norepinephrine, Spravato acts on a different neurotransmitter called glutamate. Glutamate plays a crucial role in brain plasticity, the ability of the brain to adapt and change. By targeting this pathway, Spravato can produce rapid antidepressant effects.

 

Administration and Monitoring

 

Spravato is administered as a nasal spray in a medical office or clinic under the supervision of a healthcare professional. Patients self-administer the spray and then are monitored for about two hours to ensure safety and manage any potential side effects. The treatment schedule usually involves twice-weekly sessions for the first four weeks, followed by a gradual reduction in frequency.

 

Comparing Spravato and Traditional Antidepressants

 

Speed of Relief

 

One of the most significant differences between Spravato and traditional antidepressants is the speed of relief. Traditional antidepressants can take weeks to show any effect, which can be a long and difficult wait for someone in distress. In contrast, many patients report feeling better within hours or days after starting Spravato.

 

Efficacy in Treatment-Resistant Cases

 

Spravato is specifically designed for people with treatment-resistant depression, meaning they have not responded adequately to at least two different antidepressants. For these individuals, Spravato offers a new hope when other options have failed. Traditional antidepressants, while effective for many, may not provide relief for those with more stubborn cases of depression.

 

Side Effects and Safety

 

Both Spravato and traditional antidepressants come with potential side effects. Common side effects of traditional antidepressants include nausea, weight gain, sexual dysfunction, and insomnia. Spravato's side effects can include dizziness, dissociation (a feeling of being detached from reality), and increased blood pressure, which is why monitoring after administration is essential.

 

Administration and Convenience

 

Traditional antidepressants are taken daily at home, which can be more convenient for some patients. Spravato, on the other hand, requires visits to a medical office for administration and monitoring, which may be less convenient but ensures that patients receive proper care and support during treatment.

 

Real-Life Impact

 

Let's consider the story of Mark, a 35-year-old man who has struggled with depression for most of his adult life. Mark tried several traditional antidepressants over the years, but none provided significant relief. He experienced side effects like weight gain and fatigue, which only added to his distress. Feeling hopeless, Mark was referred to a psychiatrist who suggested Spravato.

 

After just a few sessions with Spravato, Mark began to notice a change. The heavy fog of depression started to lift, and he felt more energized and hopeful. Unlike his previous treatments, Spravato worked quickly, allowing him to see improvements in days rather than weeks. Mark was able to return to work, reconnect with his family, and enjoy activities he had long abandoned.

 

Depression is a complex and challenging condition, but advancements in treatment options like Spravato offer new hope. While traditional antidepressants remain a vital tool for many, Spravato provides an alternative for those who have not found relief with conventional medications. By understanding the differences between these treatments, patients and healthcare providers can make informed decisions to best address individual needs.

 

If you or a loved one is struggling with depression, don't hesitate to reach out to our team to explore all the available depression treatment options in Apex, NC.

By Vinay Saranga September 5, 2025
Spravato is an FDA-approved nasal spray that works differently than traditional antidepressants. While most medications target serotonin or norepinephrine, Spravato boosts glutamate, which helps the brain form new connections. In simple terms, it helps “rewire” parts of the brain affected by depression.
By Vinay Saranga August 27, 2025
ADHD is one of the most common childhood mental health conditions, and while it comes with challenges, it is also highly treatable. At the North Carolina Institute of Advanced NeuroHealth, we want parents to know they don’t have to figure this out alone.
By Vinay Saranga August 7, 2025
At the North Carolina Institute of Advanced NeuroHealth, we want you to know that if your family is struggling with back-to-school anxiety or stress, you are far from alone.
By Vinay Saranga June 27, 2025
The truth is, depression can be complicated, and medication doesn’t always fix everything on its own. Lots of people don’t get the results they hope for just by taking antidepressants.
By Vinay Saranga May 28, 2025
In Fuquay-Varina and the surrounding areas, The North Carolina Institute of Advanced NeuroHealth offers care that’s rooted in compassion and respect.
By Vinay Saranga April 24, 2025
Traditional antidepressants are often the first option people try, but for some, they simply don’t do enough to bring real change. It can be discouraging when medications that worked for others don’t seem to help you, and it might make you feel like you’re running out of options.
By Vinay Saranga March 14, 2025
We’re excited to announce the expansion of our services with a brand-new office in Fuquay-Varina, NC! This new location allows us to bring expert medication management and innovative treatments like Spravato to even more people in our community. If you’ve been looking for compassionate, high-quality mental health care, we’re here for you.
By Vinay Saranga February 18, 2025
Innovative treatments like Spravato (esketamine) and ketamine therapy are changing the way we treat depression and anxiety—giving hope to those who need it most.
By Vinay Saranga January 28, 2025
For people in Apex, NC, and beyond who have struggled with depression that seems unyielding, there’s exciting news: the FDA has approved Spravato (esketamine) as the first-ever stand-alone therapy for treatment-resistant depression. This groundbreaking treatment offers new hope to those who haven’t found relief through traditional medications.
By Vinay Saranga January 2, 2025
The thing about depression is that it often doesn’t look the way we think it should. It doesn’t always look like someone crying or feeling hopeless. For many, it can show up as:
See More Posts